Transcription of DATA SHEET PRODUCT NAME QUALITATIVE AND …
{{id}} {{{paragraph}}}
Orencia 1 data SHEET 1 PRODUCT NAME ORENCIA 250 mg powder for injection ORENCIA 125 mg solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Abatacept is a fusion protein produced by recombinant DNA technology in Chinese hamster ovary cells. ORENCIA 250 mg powder for injection. Each vial contains 250 mg abatacept. Excipient with known effect Each vial contains mg sodium. ORENCIA 125mg solution for injection. Each 1 mL pre-filled syringe or autoinjector contains 125 mg abatacept Excipient with known effect Each syringe or autoinjector contains mg sodium.
Number of Vials a < 60 kg : 500 mg . 2 : 60 to 100 kg . 750 mg : 3 > 100 kg : 1 gram . 4 : a Each vial provides 250 mg of abatacept for administration. For paediatric juvenile idiopathic arthritis, a dose calculated based on each patient’s body weight is
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}